2022
DOI: 10.3390/ijerph19052875
|View full text |Cite
|
Sign up to set email alerts
|

An Intelligent System for Proper Management and Disposal of Unused and Expired Medications

Abstract: For years, several countries have been concerned about how to dispose of unused pharmaceuticals that can endanger human health and the environment. Moreover, some people are in desperate need of medical attention and medications, but they lack the financial resources to obtain them. In Saudi Arabia, there are no take-back medicine programs, and there is no published research on how medications properly are disposed. The aim of this research is to use the power of artificial intelligence to assist in the proper… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 10 publications
0
7
0
1
Order By: Relevance
“…According to [3] Not much is known about the amount of waste that pharmaceutical companies generate. However, it is widely believed that their waste has caused ethical and biological problems.…”
Section: Literature Reviewmentioning
confidence: 99%
“…According to [3] Not much is known about the amount of waste that pharmaceutical companies generate. However, it is widely believed that their waste has caused ethical and biological problems.…”
Section: Literature Reviewmentioning
confidence: 99%
“…As a result, a large part of the medications ends up in the trash, and many are completely unused and not expired [ 11 ]. Practically, many households keep significant amounts of (expired, unused, and/or unwanted) medications in their homes [ 1 , 15 , 16 , 17 ], and sometimes the storage method is wrong; when they want to get rid of unnecessary medications, households often resort to throwing them in the garbage, toilets, sinks, or sewage channels [ 15 , 17 , 18 ], and a small percentage of them are returned to unused/expired medication take-back points or pharmacies (for example, approximately 11% and 14% in India and Saudi Arabia, respectively) [ 16 , 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…In fact, medication waste is a complex issue, with economic, environmental, social, and ethical dimensions [ 15 , 18 ], and accordingly, most of the methods of medications disposal (mentioned above) fall within the irresponsible and unethical behaviors that have a serious impact on human health and the environment, including animals, water, and plants [ 20 ]. The practice of wasting medications as immoral [ 15 ] and irresponsible behavior includes the excessive purchase of medications (such as painkillers, ointments, etc. ); storage of unused medications; throwing medications in rubbish, latrines, and drains; as well as donating stored medications to relatives, friends, and neighbors [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Machine learning (Ml) has already proven its usefulness in medicine, mainly in medical image-based diagnostics, including radiology imaging, like X-ray [13] or computed tomography (Ct) [1], magnetic resonance imaging (MRi) [16] and interpretation of visual images of skin pathologies [17]. new fields of medical applications of these technologies are invented, from expedited and deepened education of medical staff [5], automated pooling data from multiple scientific studies for elevated-level analyses [18], optimisation of drugs and medical equipment supply chain and logistics [19], designing and coordinating take-back programmes for unused medications [20] to making drug supply chains counterfeit-proof [21]. by lowering the threshold of entry cost into research, that now can utilise the already existing large datasets for analyses by multiple research projects, machine learning also provides new hopes to people suffering from numerous diseases that, even if put together, affect a small part of the general population (ailments affecting 1 per 2,000 people constitute rare diseases according to the definition adopted by the european union) [22] or diseases affecting mainly the populations of poor countries, which have been thus far orphaned by the mainstream of the medical scientific community and industry as economically unattractive [23].…”
Section: Introductionmentioning
confidence: 99%